HERON THERAPEUTICS, INC. /DE/ — Form 8-K
Filed September 29, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 18/100
What the filing says
Heron Therapeutics filed Form 8-K on 2026-09-23 reporting entry into a material definitive agreement (Item 1.01). The filing header does not contain counterparty names, dollar amounts, percentages, share counts, or concrete terms of the agreement. The actual agreement details are likely in the full 8-K document text, which is not provided in this excerpt.
Why this rating
Without access to agreement details (counterparty, amount, terms), cannot assess materiality. Routine 8-K disclosure filing. Awaiting full document content for proper evaluation.
Extracted items
- 1.01 material agreement
- 9.01 exhibits
See more from September 29, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.